-
Study aim
-
The effect of antenatal Betamethasone on preventionofneonatal respiratory distress syndrome before elective cesarean section at term
-
Design
-
Non-randomized clinical trial, women with singleton pregnancy with elective cesarean section at week 37 to 38 weeks and 6 days will enroll in the study. After selecting patients and obtaining written consent, Patients were randomly assigned into either group of treatment (intramuscular betamethasone or in the control group according to the random numbers table. Then the women are routinely taken care of.
-
Settings and conduct
-
Study place:Tbriz Alzahra hospital Study procedure: Accidental division of patients into two groups of 100 patients.Treatment group: intramuscular injection of 12 mg betamethasone in two doses between 24 hours, 48 hours before cesarean section
the second groups of mothers’ were given nothing (Without receiving placebo)
,took only the usual routine care before the C/S
-
Participants/Inclusion and exclusion criteria
-
women with singleton pregnancy with elective cesarean section at week 37 to 38 weeks and 6 days will enroll in the study. Exclusion criteria include multiple pregnancies, fetus with major congenital anomalies
-
Intervention groups
-
Treatment group: intramuscular injection of 12 mg betamethasone in two doses between 24 hours, 48 hours before cesarean section
the second groups of mothers’ were given nothing
,took only the usual routine care before the C/S
-
Main outcome variables
-
Neonatal respiratory outcomes (need for CPAP or nasal cannula with high-current continuous, need for continuous high-pressure oxygen with FiO2 more than 30%, need for mechanical ventilation, need for ECMO or resuscitation at birth, respiratory distress syndrome, neonatal tachypnea, apnea, bronchopulmonary dysplasia, pneumonia, use of surfactant), the need for care in the NICU, and the duration of hospitalization.